Ignite Creation Date:
2025-12-24 @ 10:48 PM
Ignite Modification Date:
2026-04-02 @ 5:26 AM
Study NCT ID:
NCT00517569
Status:
UNKNOWN
Last Update Posted:
2008-05-12
First Post:
2007-08-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients
Sponsor:
Genexine, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GX-12_HIV_I
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Prof. Kang-Won Choe / Principal Investigator
Old Organization:
Seoul National University Hospital
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |